title: Deep gray matter involvement in neurobrucellosis.
abstract: A 27-year-old man, recent visitor to the Middle East, presented with 6-week history of fever (up to 102°F) followed by altered behavior and left hemiparesis. CSF was acellular with raised protein (138 mg/dL). CSF bacterial culture was sterile; adenosine deaminase normal (3 U/L); cryptococcal antigen, Venereal Disease Research Laboratory test, and Japanese B serology were negative. HIV serology and vasculitic workup were unremarkable. Serum Brucella agglutination titer was 320 IU (immunoglobulin M fraction 280 IU). Cranial MRI showed nonenhancing bilateral white matter and basal ganglia hyperintensities on T2-weighted images (figure, A-C). The patient was treated with IV ceftriaxone (1 month) along with oral doxycycline and rifampicin (4 months). At 3 months, Brucella agglutination titer was <20 IU and the patient became independent. Follow-up imaging showed a reduction in lesions (figure, D). Brucellosis frequently presents as chronic meningitis along with cranial neuropathies and spinal arachnoiditis.(1) Demyelinating lesions are described in neurobrucellosis,(1,2) involvement of the deep gray matter being unusual.
authors: Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
authors: Roopa
authors: R
authors: Rajan
authors: Dheeraj
authors: D
authors: Khurana
authors: Praveen
authors: P
authors: Kesav
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000032:analysis; D001479:Basal Ganglia / Q000473:pathology; D001921:Brain / Q000473:pathology*; D002006:Brucellosis / Q000276:immunology / Q000382:microbiology / Q000473:pathology*; D002443:Ceftriaxone / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D012293:Rifampin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D002443:Ceftriaxone; D004318:Doxycycline; D012293:Rifampin